BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7503569)

  • 21. [Bone changes in long-term therapy with etretinate (Tigason)].
    Haustein UF; Heilmann S
    Z Hautkr; 1987 Mar; 62(5):395-6, 399-400. PubMed ID: 3590912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rheumatologic effects of etretinate].
    Cuny JF; Schmutz JL; Terver MN; Aussedat R; Cointin M; Weber M; Beurey J
    Ann Dermatol Venereol; 1989; 116(2):95-102. PubMed ID: 2660711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hip and spinal ossification enthesopathies induced by etretinate therapy in peripheral psoriatic arthritis].
    Bologna C; Poirier JL; Hérisson C; Simon L
    Rev Rhum Mal Osteoartic; 1991 Oct; 58(9):595-9. PubMed ID: 1775906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate.
    DiGiovanna JJ; Helfgott RK; Gerber LH; Peck GL
    N Engl J Med; 1986 Nov; 315(19):1177-82. PubMed ID: 3463863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Unwanted bone changes in systemic treatment with synthetic retinoids].
    Melnik B; Plewig G
    Hautarzt; 1987 Apr; 38(4):193-7. PubMed ID: 3474220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities.
    Van Dooren-Greebe RJ; Lemmens JA; De Boo T; Hangx NM; Kuijpers AL; Van de Kerkhof PC
    Br J Dermatol; 1996 Jan; 134(1):71-6. PubMed ID: 8745889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical hyperostosis and enthesopathy due to long-term etretinate administration.
    Guit GL; Obermann WR; van der Schroeff JG; Sillevis-Smitt HJ
    Diagn Imaging Clin Med; 1986; 55(4-5):214-8. PubMed ID: 3095013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoporosis and long-term etretinate therapy.
    Margolis DJ
    Arch Dermatol; 1996 Jun; 132(6):713-4. PubMed ID: 8651730
    [No Abstract]   [Full Text] [Related]  

  • 29. Osteoporosis and long-term etretinate therapy.
    Whitmore SE
    Arch Dermatol; 1996 Jun; 132(6):713; author reply 714. PubMed ID: 8651729
    [No Abstract]   [Full Text] [Related]  

  • 30. [Retinoid treatment of pediatric skin diseases].
    Kuokkanen K
    Duodecim; 1989; 105(8):772-7. PubMed ID: 2721405
    [No Abstract]   [Full Text] [Related]  

  • 31. [Skeletal changes following long-term treatment with retinoids].
    Montag M; Reiser M; Hamm H; Traupe H; Vogt HJ
    Radiologe; 1988 Jul; 28(7):320-5. PubMed ID: 3045876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature.
    Halverstam CP; Zeichner J; Lebwohl M
    J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between bone mineral density and syndrome types described in traditional chinese medicine in chronic obstructive pulmonary disease: a preliminary clinical observation.
    Wang G; Li TQ; Mao B; Wang L; Wang L; Wang ZL; Chang J; Xiong ZY; Yang DZ
    Am J Chin Med; 2005; 33(6):867-77. PubMed ID: 16355443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extensive spinal hyperostosis in a patient receiving isotretinoin--progression after 4 years of etretinate therapy.
    Archer CB; Elias PM; Lowe NJ; Griffiths WA
    Clin Exp Dermatol; 1989 Jul; 14(4):319-21. PubMed ID: 2591100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients' acceptance of etretinate therapy. A retrospective survey of long-term etretinate therapy in chronic keratotic and pustular skin diseases.
    Christiansen JV; Holm P; Reymann F; Thestrup-Pedersen K
    Dermatologica; 1984; 168(3):122-6. PubMed ID: 6714503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral retinoids and pregnancy.
    Chan A; Hanna M; Abbott M; Keane RJ
    Med J Aust; 1996 Aug; 165(3):164-7. PubMed ID: 8709884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nature of skin fragility in patients receiving retinoids for systemic effect.
    Williams ML; Elias PM
    Arch Dermatol; 1981 Oct; 117(10):611-9. PubMed ID: 6945067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diazacholesterol-induced ichthyosis in the hairless mouse. Assay for comparative potency of topical retinoids.
    Chung JC; Law MY; Elliott ST; Elias PM
    Arch Dermatol; 1984 Mar; 120(3):342-7. PubMed ID: 6703735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Retinoid-induced changes of the bones and ligaments].
    Zelger B; Frank R; Kemmler G; Fritsch P
    Hautarzt; 1990 Oct; 41(10):537-44. PubMed ID: 2258296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transsexualism and osteoporosis.
    Schlatterer K; Auer DP; Yassouridis A; von Werder K; Stalla GK
    Exp Clin Endocrinol Diabetes; 1998; 106(4):365-8. PubMed ID: 9792472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.